U.S. Senator Warns About Loss of Control Over AI Amid Industry Calls for Slowdown
Senator Richard Blumenthal, chairing the Senate Judiciary Subcommittee on Privacy, Technology and the Law, warned that the U.S. is nearing a loss of control over artificial intelligence (AI). Speaking to CNBC, he proposed an FDA-style regulatory framework requiring government review before AI products are released publicly. His comments have spurred action in both industry and Congress. In response, Anthropic CEO Dario Amodei published a lengthy essay urging the sector to slow down development due to safety concerns, while OpenAI’s Sam Altman echoed similar sentiments on social media. These developments coincided with two bipartisan bills introduced in July aimed at giving federal authorities power over AI systems deemed risky. For investors and companies developing advanced models like ChatGPT or Anthropic's offerings, the proposed regulatory changes could lead to significant delays and increased compliance costs before products reach market.
Topics: AI regulation congressional action government oversight